Physician profile
Stephen E Farmer
NPI 1629056841
$1,454.00
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,454.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $333.21 | 2019 | |
| Avanir Pharmaceuticals, INC. | $160.50 | 2019 | |
| Novartis Pharmaceuticals Corporation | $156.84 | 2019 | |
| Ucb, INC. | $138.69 | 2019 | |
| Amgen INC. | $130.35 | 2019 | |
| Lilly USA, LLC | $112.49 | 2019 | |
| Biogen, INC. | $85.69 | 2019 | |
| Adamas Pharmaceuticals, INC. | $66.82 | 2019 | |
| Emd Serono, INC. | $35.72 | 2019 | |
| Eisai INC. | $35.44 | 2019 | |
| Promius Pharma LLC | $32.89 | 2019 | |
| Amneal Pharmaceuticals LLC | $32.15 | 2019 | |
| Alexion Pharmaceuticals, INC. | $26.77 | 2019 | |
| Akcea Therapeutics, INC. | $24.43 | 2019 | |
| Supernus Pharmaceuticals, INC. | $16.30 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $15.88 | 2019 | |
| Abbvie INC. | $13.62 | 2019 | |
| Jazz Pharmaceuticals INC. | $12.80 | 2019 | |
| Grifols USA, LLC | $11.71 | 2019 | |
| Mallinckrodt Enterprises LLC | $11.70 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Farmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.